PROTOCOL BMS IM026-024 A Phase 2, Multicenter, Randomized, Double-
blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of
Afimetoran in Participants With Active Systemic Lupus Erythematosus
Clinicaltrial.gov website:
https://www.clinicaltrials.gov/ct2/show/NCT04895696?cond=Systemic+Lupus+Eryt
hematosus&cntry=US&state=US%3AMN&city=eagan&draw=2&rank=1
Study website:
https://lupusnewstoday.com/news/phase-2-trial-oral-afimetoran-for-sle-now-
underway-formerly-bms-986256/
https://www.bms.com/
PROTOCOL RC18001 A Multicenter, Randomized, Double-Blind, Placebo-
Controlled, 2-Stage Trial to Evaluate Efficacy and Safety of Telitacicept
Compared to Placebo in Patients With Moderately to Severely Active Systemic Lupus Erythematosus
Clinicaltrial.gov website